Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Carney Technology Acquisition Corp. II Announces Pricing of $ $350,000,000 Initial Public Offering
-
Carney Technology Acquisition Corp. II Announces Pricing of $ $350,000,000 Initial Public Offering
-
Cantor Fitzgerald Starts Chinook Therapeutics (KDNY) at Overweight
-
Phreesia Inc. (PHR) PT Raised to $55 at Cantor Fitzgerald
-
Curis (CRIS) Prices 25.65M Share Common Stock Offering at $5.75/share
-
Curis Announces Pricing of Public Offering of Common Stock
-
Altitude Acquisition Corp. (ALTU) Prices 26.1M Unit IPO at $10/Unit
-
Looking For The Best Penny Stocks? 4 With Price Targets Up To 419%
-
Altitude Acquisition Corp. Announces Pricing of $261 Million Initial Public Offering
-
Altitude Acquisition Corp. Announces Pricing of $261 Million Initial Public Offering
-
FinTech Acquisition Corp. V Announces Completion of $250,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option
-
FinTech Acquisition Corp. V Announces Completion of $250,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option
-
PropTech Investment Corporation II Announces Closing of Upsized $230,000,000 Initial Public Offering
-
PropTech Investment Corporation II Announces Closing of Upsized $230,000,000 Initial Public Offering
-
Curis (CRIS) Announces Proposed Public Offering of Common Stock
-
Curis Announces Proposed Public Offering of Common Stock
-
Marinus Pharma (MRNS) Prices 5M Share Common Offering for Gross Proceeds of $70M
-
Marinus Pharmaceuticals Announces Pricing of $70 Million Public Offering of Common Stock
-
iBio, Inc. (IBIO) Prices 29.7M Share Common Stock Offering from Proceeds of $35M
-
iBio Announces Pricing of $35 Million Public Offering of Common Stock
-
Ocuphire to be Featured in Cantor Fitzgerald Fireside Chat with Equity Research Analyst Kristen Kluska
-
Are These Biotech Penny Stocks To Buy Before 2021? 3 Names To Know
-
Amryt Announces $40m Private Placement with Leading Biotech Investors
-
Amryt Announces $40m Private Placement with Leading Biotech Investors
-
ALX Oncology (ALXO) Announces 2M Share Proposed Public Offering of Common Stock
-
ALX Oncology Announces Proposed Public Offering of Common Stock
-
ALX Oncology Announces Proposed Public Offering of Common Stock
-
iBio, Inc. (IBIO) Announces Proposed Common Share Offering
-
Marinus Pharma (MRNS) to Offer Common Stock
-
iBio Announces Proposed Public Offering of Common Stock
-
Marinus Pharmaceuticals Announces Underwritten Public Offering of Common Stock
-
Are These The Best Penny Stocks To Buy Now? 4 With 9%-626% Targets
-
5 Biotech Penny Stocks To Watch With Recent & Upcoming Events
-
Looking For Penny Stocks To Buy? 4 Small Cap Stocks Up Big This Week
-
FinTech Acquisition Corp. V (FTCV) Prices 21.8M Unit IPO at $10/Unit
-
PropTech Investment Corporation II (PTIC) Prices 20M Unit IPO at $10/Unit
-
FinTech Acquisition Corp. V Announces Pricing of $218,000,000 Initial Public Offering
-
FinTech Acquisition Corp. V Announces Pricing of $218,000,000 Initial Public Offering
-
PropTech Investment Corporation II Announces Pricing of Upsized $200,000,000 Initial Public Offering
-
PropTech Investment Corporation II Announces Pricing of Upsized $200,000,000 Initial Public Offering
-
Looking For Small Cap Stocks To Buy Under $5? 4 Penny Stocks To Watch
-
UPDATE: Cantor Fitzgerald Downgrades Omnicell (OMCL) to Neutral on Valuation
-
Curaleaf Announces Participation at December Conferences & Events
-
Silverstein Properties And Cantor Fitzgerald Partner With University Place Associates To Develop Life Science Project In Philadelphia Opportunity Zone
-
Axsome Therapeutics (AXSM) PT Raised to $161 at Cantor Fitzgerald, Following Clinical Trial Update
-
Freddie Mac Prices $983 Million Multifamily K-Deal, K-F94
-
Pre-Open Stock Movers 12/01: (BB) (MRNA) (KSS) Higher; (FOUR) (NOVA) (ZM) Lower (more...)
-
Green Thumb Industries Announces Conference Participation for December 2020
-
CarepathRx and UPMC Announce Landmark Partnership to Bring Comprehensive Pharmacy Care Solutions to More Patients
-
Green Thumb Industries Announces Conference Participation for December 2020

